Objective: To evaluate placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) as early predictors of pre-eclampsia. Methods: Cohort study at Department of Obstetrics and Gynecology, Ain Shams University Hospitals, enrolling eighty pregnant women between 14 and 19 weeks’ gestation, sera were collected, and stored at -80°C. Thirty women developed pre-eclampsia, fifty continued to be normotensive and their second blood samples were collected. Serum sFlt-1 and PlGF were assayed using chemiluminescence. All enrolled subjects were divided into Q1, Q2, Q3 and Q4 according to serum levels of sFlt-1, PlGF and sFlt-1/PlGF
Background. To assess the ability of mid-trimester sFlt-1/PlGF ratio for prediction of preeclampsia ...
Objective: The aim of this study is to identify the role of sFlt-1/PIGF ratio as a prognostic marker...
Soluble fms-like tyrosine kinase 1 (sFlt-1) is an anti-angiogenic factor released in higher amounts ...
Management of pregnant women at high risk of pre-eclampsia (PE) requires frequent monitoring, with r...
Soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF) contribute in the dev...
The ratio of soluble fms-like tyrosine kinase 1 (sFlt-1) to placental growth factor (PlGF) is elevat...
The ratio of soluble fms-like tyrosine kinase 1 (sFlt-1) to placental growth factor (PlGF) is elevat...
OBJECTIVE: We aimed to investigate how maternal serum soluble Fms-like kinase 1 (sFlt-1), placental ...
OBJECTIVE: We aimed to investigate how maternal serum soluble Fms-like kinase 1 (sFlt-1), placental ...
We sought to assess the ratio of sFlt-1 (soluble fms-like tyrosine kinase 1) to PlGF (placental grow...
Objectives: The soluble fm--s-like tyrosine kinase-1 (sFlt-1) to placental growth factor (PlGF) rati...
Objectives The soluble fms‐like tyrosine kinase‐1 (sFlt‐1) to placental growth factor (PlGF) ratio ...
BACKGROUND: The ratio of soluble fms-like tyrosine kinase 1 (sFlt-1) to placental growth factor (PlG...
<p><i>Objective</i>: We aimed to investigate how maternal serum soluble Fms-like kinase 1 (sFlt-1), ...
Preeclampsia (PE) is characterized by placental and maternal endothelial dysfunction, and associated...
Background. To assess the ability of mid-trimester sFlt-1/PlGF ratio for prediction of preeclampsia ...
Objective: The aim of this study is to identify the role of sFlt-1/PIGF ratio as a prognostic marker...
Soluble fms-like tyrosine kinase 1 (sFlt-1) is an anti-angiogenic factor released in higher amounts ...
Management of pregnant women at high risk of pre-eclampsia (PE) requires frequent monitoring, with r...
Soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF) contribute in the dev...
The ratio of soluble fms-like tyrosine kinase 1 (sFlt-1) to placental growth factor (PlGF) is elevat...
The ratio of soluble fms-like tyrosine kinase 1 (sFlt-1) to placental growth factor (PlGF) is elevat...
OBJECTIVE: We aimed to investigate how maternal serum soluble Fms-like kinase 1 (sFlt-1), placental ...
OBJECTIVE: We aimed to investigate how maternal serum soluble Fms-like kinase 1 (sFlt-1), placental ...
We sought to assess the ratio of sFlt-1 (soluble fms-like tyrosine kinase 1) to PlGF (placental grow...
Objectives: The soluble fm--s-like tyrosine kinase-1 (sFlt-1) to placental growth factor (PlGF) rati...
Objectives The soluble fms‐like tyrosine kinase‐1 (sFlt‐1) to placental growth factor (PlGF) ratio ...
BACKGROUND: The ratio of soluble fms-like tyrosine kinase 1 (sFlt-1) to placental growth factor (PlG...
<p><i>Objective</i>: We aimed to investigate how maternal serum soluble Fms-like kinase 1 (sFlt-1), ...
Preeclampsia (PE) is characterized by placental and maternal endothelial dysfunction, and associated...
Background. To assess the ability of mid-trimester sFlt-1/PlGF ratio for prediction of preeclampsia ...
Objective: The aim of this study is to identify the role of sFlt-1/PIGF ratio as a prognostic marker...
Soluble fms-like tyrosine kinase 1 (sFlt-1) is an anti-angiogenic factor released in higher amounts ...